Streetbeat News

Price Targets

CHD

Morgan Stanley analyst Dara Mohsenian maintains an Overweight rating on Church & Dwight Co (NYSE:CHD) and raises the price target from $106 to $114.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 9:25 am

CB

Morgan Stanley analyst Michael Phillips has maintained an Equal-Weight rating on Chubb (NYSE:CB) and raised the price target from $192 to $209.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 9:24 am

URBN

Urban Outfitters (NASDAQ:URBN) has received a mix of bullish and indifferent analyst ratings in the last quarter. According to 11 analysts, the average 12-month price target for the company is $34.82, with a high of $45.00 and a low of $29.00. This average price target has increased by 16.07% over the past month.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 9:20 am

CC

Morgan Stanley analyst Vincent Andrews has reiterated an Equal-Weight rating on Chemours (NYSE:CC) and maintained a $33 price target.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 9:20 am

FUN

Morgan Stanley analyst Thomas Yeh has maintained an Overweight rating on Cedar Fair (NYSE:FUN) but lowered the price target from $53 to $48.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 9:20 am

CHTR

Morgan Stanley analyst Benjamin Swinburne has reiterated an Equal-Weight rating on Charter Communications (NASDAQ:CHTR) and maintained a price target of $460.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 9:20 am

BNTX

Morgan Stanley analyst Matthew Korn has reiterated an Equal-Weight rating on BioNTech (NASDAQ:BNTX) and maintained a price target of $119.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 9:19 am

BMRN

Morgan Stanley analyst Matthew Harrison has maintained an 'Overweight' rating on Biomarin Pharmaceutical (NASDAQ:BMRN) but lowered the price target from $129 to $125.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 9:19 am

AVNT

Morgan Stanley analyst Angel Castillo has reiterated an Equal-Weight rating on Avient (NYSE:AVNT) and maintained a $40 price target.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 9:19 am

AVTR

Morgan Stanley analyst Tejas Savant has maintained an Overweight rating on Avantor (NYSE:AVTR) but lowered the price target from $26 to $24.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 9:19 am